Palmar plantar erythrodysesthesia epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
Overview
Palmar plantar erythrodysesthesia (PPE) has been reported to occur in 6 – 64% of patients treated with different chemotherapy regimens. However, the exact incidence of PPE is unknown, as most reports are isolated case reports or short case series.
Epidemiology and Demographics
Epidemiology and Demographics
Incidence
- Based on some case series, palmar plantar erythrodysesthesia (PPE) has been reported to occur in 6 – 64% of patients treated with different chemotherapy regimens. [1]
References
References
- ↑ L. Hueso, O. Sanmartin, E. Nagore, R. Botella-Estrada, C. Requena, B. Llombart, C. Serra-Guillen, A. Alfaro-Rubio & C. Guillen. “[Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases]”. Actas dermo-sifiliograficas. PMID 18394404.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH